- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TickerReport.com reported that pure-play molybdenum miner Thompson Creek Metals Company Inc. (TSX:TCM,NYSE:TC) has been downgraded by analysts at Bank of America Corp. (NYSE:BAC) to an “underperform” rating from “neutral.”
TickerReport.com reported that pure-play molybdenum miner Thompson Creek Metals Company Inc. (TSX:TCM,NYSE:TC) has been downgraded by analysts at Bank of America Corp. (NYSE:BAC) to an “underperform” rating from “neutral.”
As quoted in the market news:
The analysts wrote, “We are downgrading Thompson Creek Metals Co. Inc. (TCM) to an Underperform from Neutral rating, and lowering our price objective (PO) to $3.00/share from $4.00, following our commodities team downgrade of our 2013-15 molybdenum (moly – Mo) and gold (Au) price forecasts, due to weakening fundamentals (higher than expected near-term supply for moly and tapering on gold). TCM announced first concentrate production at its Mt. Milligan copper-gold development project on September 24th, after 3 years of construction that saw capex overruns north of $750mn in the $1.6B project. While we continue to expect Mt. Milligan to improve TCM’s EBITDA ($56mn in 2013 to $486mn in 2015), we believe that risks in TCM shares have increased because the company will have to rely on its relatively high cost moly operations (Thompson Creek and Endako mines) during Mt. Milligan’s ramp up (~12 months) under a weak moly price environment.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.